Author

K. Berman

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2 Bioengineering· 1 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:drug response / drug discovery· 2 Research Focus:host-pathogen & immune response· 2 Organism:human· 2 Organism:mouse· 2 Assay:proteomics· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1

Frequent Co-Authors

G. Van Slyke· 2 shared N. J. MANTIS· 2 shared A. Acuna-Ruiz· 1 shared A. Damjanovic· 1 shared A. Dupuis· 1 shared A. R. Glover· 1 shared B. R. Untch· 1 shared B. Xu· 1 shared

Activity by Year

2022-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 17 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

G. Van Slyke

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

RBM10 loss induces aberrant splicing of cytoskeletal and extracellular matrix mRNAs and promotes metastatic fitness.

G. P. Krishnamoorthy, A. R. Glover, B. R. Untch, N. F. Sigcha-Coello, B. Xu, D. Vukel, Y. Liu, V. Tiedje, K. Berman, P. P. Tamarapu, A. Acuna-Ruiz, M. Saqcena, E. de Stanchina, L. Boucai, R. A. Ghossein, , J. A. Fagin

This study shows that RBM10 loss causes aberrant splicing of cytoskeletal and ECM genes, leading to RAC1 activation and metastatic fitness in thyroid cancer.

bioRxiv · Jul 9, 2024 · PreprintCancer Biology

Quantitating SARS-CoV-2 Neutralizing Antibodies from Human Dried Blood Spots

K. Berman, G. Van Slyke, H. Novak, J. Rock, R. Bievenue, A. Damjanovic, K. DeRosa, G. Mirabile, R. Giradin, A. Dupuis, K. McDonough, M. M. Parker, L. Styer, N. J. MANTIS

This study evaluates the use of dried blood spots (DBS) to quantify SARS-CoV-2 neutralizing antibodies using multiple assays, finding that DBS eluates can reliably measure neutralizing titers.

bioRxiv · Mar 18, 2024Immunology

Effects of aluminum-salt, CpG and emulsion adjuvants on the stability and immunogenicity of a virus-like particle displaying the SARS-CoV-2 receptor binding domain (RBD)

O. S. Kumru, S. Bajoria, K. Kaur, J. M. Hickey, G. Van Slyke, J. Doering, K. Berman, C. Richardson, H. Lien, H. Kleanthous, N. J. Mantis, S. B. Joshi, D. B. Volkin

This paper evaluates the stability and immunogenicity of a SARS-CoV-2 RBD VLP vaccine candidate formulated with different adjuvants and finds that AP and AH adjuvants provide comparable immunogenicity to AV, with AP showing higher neutralizing titers.

bioRxiv · Jul 10, 2023Immunology

Bioengineering multifunctional extracellular vesicles for targeted delivery of biologics to T cells

D. Stranford, L. M. Simons, K. Berman, L. Cheng, J. B. Lucks, J. F. Hultquist, J. N. Leonard

This paper develops methods to engineer extracellular vesicles for targeted delivery of biologics to T cells, demonstrating efficient cargo delivery using Cas9-sgRNA complexes.

bioRxiv · May 14, 2022Bioengineering